September 27, 2022 —  Martha Gulati, MD, an expert in preventive cardiology and women’s heart disease, has joined the Smidt Heart Institute as director of Preventive Cardiology, associate director of the Preventive and Rehabilitative Cardiac Center and associate director of the Barbra Streisand Women’s Heart Center in the Depa

September 27, 2022 —  Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular disorders, reported that a late breaking abstract describing dose response data from its positive Phase 2 clinical study of istaroxime in early cardiogenic shock (SEISMiC) will be presented on October 2 at the 

September 26, 2022 — Kawasaki disease (KD) is the leading cause of acquired heart disease in children in developed countries, yet it has long defied easy understanding, with 

September 26, 2022 — ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced the detailed resul